Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of ATP metabolic process. [GO_REF:0000058, GOC:TermGenie, PMID:20695849]
Negative regulation of ATP metabolic process involves a complex interplay of regulatory mechanisms that modulate the production and utilization of ATP, the primary energy currency of cells. This process is essential for maintaining cellular homeostasis and ensuring proper functioning of various cellular processes. Here's a detailed description:
1. **Feedback Inhibition:** ATP itself can act as an allosteric inhibitor of key enzymes involved in its own production, such as phosphofructokinase (PFK-1) in glycolysis and citrate synthase in the citric acid cycle. This feedback mechanism prevents excessive ATP accumulation and ensures efficient energy production.
2. **Regulation of Enzyme Activity:** A variety of factors can influence the activity of enzymes involved in ATP metabolism. These factors include:
* **Phosphorylation:** Phosphorylation of specific enzymes can either activate or deactivate them. For instance, phosphorylation of PFK-1 stimulates its activity, promoting glycolysis and ATP production.
* **Allosteric Regulation:** Binding of specific molecules to regulatory sites on enzymes can alter their activity. For example, AMP, a product of ATP hydrolysis, can activate PFK-1, stimulating glycolysis.
* **Hormonal Control:** Hormones like insulin and glucagon play crucial roles in regulating ATP metabolism. Insulin promotes glucose uptake and utilization, leading to increased ATP production, while glucagon stimulates glycogen breakdown and gluconeogenesis, providing alternative substrates for ATP generation.
3. **Regulation of Substrate Availability:** The availability of substrates like glucose, fatty acids, and amino acids influences ATP production. Processes like glucose uptake, fatty acid mobilization, and amino acid catabolism are tightly regulated to ensure a constant supply of substrates for ATP generation.
4. **Control of Electron Transport Chain:** The electron transport chain in mitochondria is a critical component of ATP production. This chain's activity is regulated by factors such as oxygen availability, proton gradient across the mitochondrial membrane, and the presence of inhibitors like cyanide.
5. **Regulation of ATP Consumption:** Cellular processes that require ATP, such as muscle contraction, protein synthesis, and active transport, are carefully regulated to prevent excessive energy expenditure.
6. **Mitochondrial Biogenesis:** The number and activity of mitochondria, the powerhouses of the cell, are regulated in response to energy demands. When ATP levels are low, mitochondrial biogenesis increases to enhance ATP production capacity.
7. **Adaptive Mechanisms:** Cells can adapt to changes in energy availability by altering their metabolic pathways. For instance, under low oxygen conditions, cells switch to anaerobic respiration, producing ATP through glycolysis without the need for oxygen.
These regulatory mechanisms work in concert to maintain ATP levels within a narrow range, ensuring optimal cellular function and survival. Negative regulation of ATP metabolic process is crucial for maintaining cellular homeostasis and preventing energy depletion.
'"
Protein | Definition | Taxonomy |
---|---|---|
Translocator protein | [no definition available] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
pk 11195 | PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine | aromatic amide; isoquinolines; monocarboxylic acid amide; monochlorobenzenes | antineoplastic agent |
ro 5-4864 | 4'-chlorodiazepam: selectively binds peripheral benzodiazepine receptor | ||
clonazepam | clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation. Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. | 1,4-benzodiazepinone; monochlorobenzenes | anticonvulsant; anxiolytic drug; GABA modulator |
nordazepam | nordazepam : A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety. Nordazepam: An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam. | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative |
diazepam | diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
flunitrazepam | flunitrazepam : A 1,4-benzodiazepinone that is nitrazepam substituted by a methyl group at position 1 and by a fluoro group at position 2'. It is a potent hypnotic, sedative, and amnestic drug used to treat chronic insomnia. Flunitrazepam: A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. | 1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes | anxiolytic drug; GABAA receptor agonist; sedative |
lorazepam | Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. | benzodiazepine | |
nitrazepam | nitrazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). Nitrazepam: A benzodiazepine derivative used as an anticonvulsant and hypnotic. | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative |
cm 7116 | norflutoprazepam: structure | benzodiazepine | |
oxazepam | oxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5. Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. | 1,4-benzodiazepinone; organochlorine compound | anxiolytic drug; environmental contaminant; xenobiotic |
temazepam | Temazepam: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent. | benzodiazepine | |
chlordesmethyldiazepam | benzodiazepine | ||
halazepam | halazepam: structure | organic molecular entity | |
alpidem | imidazoles | ||
n-desmethylflunitrazepam | |||
7-aminonitrazepam | 7-aminonitrazepam: urinary metabolite of nitrazepam | benzodiazepine | |
ro 20-1815 | 7-aminoflunitrazepam: flunitrazepam metabolite; structure given in first source | benzodiazepine | |
dx 9065 | |||
ro 11-6893 | Ro 11-6893: RN given refers to (R)-isomer | ||
n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide | N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide: binds with high affinity to glial mitochondrial diazepam binding inhibitor receptors & increases mitochondrial steroidogenesis | phenylindole | |
7-aminoclonazepam | benzodiazepine | ||
ro 5-3438 | Ro 5-3438: structure | ||
n-desmethylflunitrazepam | N-desmethylflunitrazepam: metabolite of flunitrazepam | ||
ro 05-4082 | ID 690: methyl deriv of clonazepam; structure | ||
ac-5216 | |||
cb 34 | CB 34: ligand for peripheral benzodiazepine receptors; structure in first source | ||
n-(2-methoxybenzyl)-n-(4-phenoxypyridin-3-yl)acetamide | N-(2-methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide: for imaging brain peripheral benzodiazepine receptors; structure in first source | ||
ssr180575 | SSR180575: structure in first source | ||
daa 1106 | |||
naluzotan | naluzotan: an antidepressant and anti-anxiety agent; structure in first source | ||
dpa-713 | |||
a 803467 | A 803467: an Nav1.8 sodium channel blocker; structure in first source | ||
n-fluoroacetyl-n-(2,5-dimethoxybenzyl)-2-phenoxyaniline | N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline: a peripheral benzodiazepine receptor PET ligand; structure in first source | ||
MS-417 | MS-417 : A member of the class of thienotriazolodiazepines that is the methyl ester of [(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetic acid. A bromodomain and extra-terminal domain (BET)-specific inhibitor that belongs to a group of thienodiazepine-based compounds | methyl ester; monochlorobenzenes; thienotriazolodiazepine |